113 related articles for article (PubMed ID: 30178516)
1. Should sodium-glucose co-transporter-2 inhibitors be considered as first-line oral therapy for people with type 2 diabetes?
Khunti K; Seidu S; Davies MJ
Diabetes Obes Metab; 2019 Feb; 21(2):207-209. PubMed ID: 30178516
[No Abstract] [Full Text] [Related]
2. Which person with diabetes should receive cardioprotective glucose-lowering medicines?
Bloomgarden ZT
J Diabetes; 2020 May; 12(5):352-353. PubMed ID: 32119186
[No Abstract] [Full Text] [Related]
3. Does SGLT1 Inhibition Add Benefit to SGLT2 Inhibition in Type 2 Diabetes?
Pitt B; Bhatt DL
Circulation; 2021 Jul; 144(1):4-6. PubMed ID: 33887961
[No Abstract] [Full Text] [Related]
4. Approaches to treatment 1: How is type 2 diabetes actually treated?
Bloomgarden ZT
J Diabetes; 2015 Nov; 7(6):747-8. PubMed ID: 26211568
[No Abstract] [Full Text] [Related]
5. SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management.
van Baar MJB; van Ruiten CC; Muskiet MHA; van Bloemendaal L; IJzerman RG; van Raalte DH
Diabetes Care; 2018 Aug; 41(8):1543-1556. PubMed ID: 30030256
[TBL] [Abstract][Full Text] [Related]
6. Fixed-dose combination of ertugliflozin and metformin hydrochloride for the treatment of type 2 diabetes.
Frias JP
Expert Rev Endocrinol Metab; 2019 Mar; 14(2):75-83. PubMed ID: 30724637
[TBL] [Abstract][Full Text] [Related]
7. Comparison of glucose-lowering agents after dual therapy failure in type 2 diabetes: A systematic review and network meta-analysis of randomized controlled trials.
Zaccardi F; Dhalwani NN; Dales J; Mani H; Khunti K; Davies MJ; Webb DR
Diabetes Obes Metab; 2018 Apr; 20(4):985-997. PubMed ID: 29205774
[TBL] [Abstract][Full Text] [Related]
8. [Oral diabetes treatment. Which substance is indicated at which time?].
Hamann A; Morcos M; Nawroth P
Internist (Berl); 2004 Dec; 45(12):1356-63. PubMed ID: 15536516
[TBL] [Abstract][Full Text] [Related]
9. Sodium-glucose cotransporter-2 inhibitors in type 2 diabetes: a magic potion to reduce heart failure?
Pafili K; Papanas N
Expert Rev Clin Pharmacol; 2019 Aug; 12(8):693-695. PubMed ID: 31232616
[No Abstract] [Full Text] [Related]
10. [Metformin. Mode of action and effect of monotherapy and combination therapy on glucose metabolism in type 2 diabetes].
Christiansen AL; Madsbad S
Ugeskr Laeger; 2002 Apr; 164(15):2025-8. PubMed ID: 11985000
[TBL] [Abstract][Full Text] [Related]
11. Replacement Effects and Budget Impacts of Insurance Coverage for Sodium-Glucose Co-Transporter-2 Inhibitors on Oral Antidiabetic Drug Utilization.
Chen HY; Chiu PY; Chang CJ; Tsai LL; Huang YL; Hsu JC
Clin Drug Investig; 2018 Dec; 38(12):1125-1133. PubMed ID: 30219950
[TBL] [Abstract][Full Text] [Related]
12. Pharmacoeconomic evaluation of sodium-glucose transporter-2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
Rahman W; Solinsky PJ; Munir KM; Lamos EM
Expert Opin Pharmacother; 2019 Feb; 20(2):151-161. PubMed ID: 30412008
[TBL] [Abstract][Full Text] [Related]
13. Empagliflozin/metformin fixed-dose combination: a review in patients with type 2 diabetes.
Hu J; Zou P; Zhang S; Zhou M; Tan X
Expert Opin Pharmacother; 2016 Dec; 17(18):2471-2477. PubMed ID: 27819159
[TBL] [Abstract][Full Text] [Related]
14. [Blood glucose control with high dosage metformin. So that sweet hearts beat longer].
MMW Fortschr Med; 2002 Jun; 144(24):46-7. PubMed ID: 12138888
[No Abstract] [Full Text] [Related]
15. Canagliflozin/metformin Fixed-dose Combination: National Evidence, Global Relevance.
Kalra S; Kapoor N
J Assoc Physicians India; 2024 Apr; 72(4):11. PubMed ID: 38881076
[No Abstract] [Full Text] [Related]
16. Beneficial effects of addition of oral spray insulin (Oralin) on insulin secretion and metabolic control in subjects with type 2 diabetes mellitus suboptimally controlled on oral hypoglycemic agents.
Guevara-Aguirre J; Guevara M; Saavedra J; Mihic M; Modi P
Diabetes Technol Ther; 2004 Feb; 6(1):1-8. PubMed ID: 15000763
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of type 2 diabetes].
Meier JJ
Internist (Berl); 2016 Feb; 57(2):153-65. PubMed ID: 26795946
[TBL] [Abstract][Full Text] [Related]
18. Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes.
Raskin P
Diabetes Obes Metab; 2008 Dec; 10(12):1167-77. PubMed ID: 18494804
[TBL] [Abstract][Full Text] [Related]
19. Progression through diabetes therapies among new elderly users of metformin: a population-based study.
Gomes T; Juurlink DN; Shah BR; Hellings CR; Paterson JM; Mamdani MM
Diabet Med; 2013 Feb; 30(2):e51-5. PubMed ID: 23075391
[TBL] [Abstract][Full Text] [Related]
20. A survey: perioperative diabetes medications and glucose control-time to re-examine management?
Brown R; Siddiqui U; Paul J
Can J Anaesth; 2019 May; 66(5):621-622. PubMed ID: 30726550
[No Abstract] [Full Text] [Related]
[Next] [New Search]
